Oil & Gas Refining & Marketing
Compare Stocks
5 / 10Stock Comparison
AMTX vs XOM vs CVX vs GEVO vs COP
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Chemicals - Specialty
Oil & Gas Exploration & Production
AMTX vs XOM vs CVX vs GEVO vs COP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Refining & Marketing | Oil & Gas Integrated | Oil & Gas Integrated | Chemicals - Specialty | Oil & Gas Exploration & Production |
| Market Cap | $213M | $620.85B | $364.18B | $493M | $140.02B |
| Revenue (TTM) | $209M | $323.90B | $184.43B | $174M | $58.31B |
| Net Income (TTM) | $-74M | $28.84B | $12.30B | $-11M | $7.32B |
| Gross Margin | 3.4% | 21.7% | 30.4% | 23.4% | 29.2% |
| Operating Margin | -13.4% | 10.5% | 9.0% | -4.6% | 18.3% |
| Forward P/E | — | 14.8x | 15.0x | — | 13.3x |
| Total Debt | $318M | $43.54B | $46.74B | $168M | $23.44B |
| Cash & Equiv. | $5M | $10.68B | $6.47B | $1M | $6.50B |
AMTX vs XOM vs CVX vs GEVO vs COP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Aemetis, Inc. (AMTX) | 100 | 390.0 | +290.0% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| Gevo, Inc. (GEVO) | 100 | 157.4 | +57.4% |
| ConocoPhillips (COP) | 100 | 272.4 | +172.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMTX vs XOM vs CVX vs GEVO vs COP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMTX is the #2 pick in this set and the best alternative if momentum is your priority.
- +140.0% vs COP's +34.7%
XOM ranks third and is worth considering specifically for efficiency.
- 6.4% ROA vs AMTX's -29.3%, ROIC 8.6% vs -70.3%
CVX is the clearest fit if your priority is dividends.
- 3.8% yield, 8-year raise streak, vs XOM's 2.7%, (2 stocks pay no dividend)
GEVO is the clearest fit if your priority is growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs AMTX's -22.3%
COP carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.08, yield 2.8%
- 233.4% 10Y total return vs XOM's 105.0%
- Lower volatility, beta 0.08, Low D/E 36.4%, current ratio 1.30x
- Beta 0.08, yield 2.8%, current ratio 1.30x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs AMTX's -22.3% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.6% margin vs AMTX's -35.4% | |
| Stability / Safety | Beta 0.08 vs GEVO's 1.64 | |
| Dividends | 3.8% yield, 8-year raise streak, vs XOM's 2.7%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +140.0% vs COP's +34.7% | |
| Efficiency (ROA) | 6.4% ROA vs AMTX's -29.3%, ROIC 8.6% vs -70.3% |
AMTX vs XOM vs CVX vs GEVO vs COP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AMTX vs XOM vs CVX vs GEVO vs COP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
COP leads in 3 of 6 categories
AMTX leads 0 • XOM leads 0 • CVX leads 0 • GEVO leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
COP leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 1857.1x GEVO's $174M. COP is the more profitable business, keeping 12.6% of every revenue dollar as net income compared to AMTX's -35.4%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $209M | $323.9B | $184.4B | $174M | $58.3B |
| EBITDAEarnings before interest/tax | -$21M | $59.9B | $37.1B | $18M | $22.4B |
| Net IncomeAfter-tax profit | -$74M | $28.8B | $12.3B | -$11M | $7.3B |
| Free Cash FlowCash after capex | -$38M | $23.6B | $16.2B | -$35M | $18.3B |
| Gross MarginGross profit ÷ Revenue | +3.4% | +21.7% | +30.4% | +23.4% | +29.2% |
| Operating MarginEBIT ÷ Revenue | -13.4% | +10.5% | +9.0% | -4.6% | +18.3% |
| Net MarginNet income ÷ Revenue | -35.4% | +8.9% | +6.7% | -6.6% | +12.6% |
| FCF MarginFCF ÷ Revenue | -18.2% | +7.3% | +8.8% | -19.9% | +31.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.4% | -1.3% | -5.3% | +47.5% | -2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +29.8% | -11.0% | -24.5% | +3.8% | -20.2% |
Valuation Metrics
COP leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 18.1x trailing earnings, COP trades at a 34% valuation discount to CVX's 27.5x P/E. On an enterprise value basis, COP's 6.8x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $213M | $620.8B | $364.2B | $493M | $140.0B |
| Enterprise ValueMkt cap + debt − cash | $526M | $653.7B | $404.5B | $659M | $157.0B |
| Trailing P/EPrice ÷ TTM EPS | -2.44x | 21.86x | 27.53x | -14.50x | 18.09x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.79x | 15.02x | — | 13.29x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 10.91x | 10.89x | 102.12x | 6.77x |
| Price / SalesMarket cap ÷ Revenue | 1.02x | 1.92x | 1.97x | 3.07x | 2.38x |
| Price / BookPrice ÷ Book value/share | — | 2.37x | 1.76x | 1.01x | 2.23x |
| Price / FCFMarket cap ÷ FCF | — | 26.29x | 21.95x | — | 8.35x |
Profitability & Efficiency
COP leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
COP delivers a 11.3% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-2 for GEVO. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to COP's 0.36x. On the Piotroski fundamental quality scale (0–9), COP scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +10.7% | +7.2% | -2.4% | +11.3% |
| ROA (TTM)Return on assets | -29.3% | +6.4% | +4.2% | -1.7% | +6.0% |
| ROICReturn on invested capital | -70.3% | +8.6% | +6.2% | -2.8% | +10.4% |
| ROCEReturn on capital employed | -19.0% | +8.9% | +6.6% | -3.1% | +10.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 5 | 4 | 6 |
| Debt / EquityFinancial leverage | — | 0.16x | 0.24x | 0.36x | 0.36x |
| Net DebtTotal debt minus cash | $313M | $32.9B | $40.3B | $166M | $16.9B |
| Cash & Equiv.Liquid assets | $5M | $10.7B | $6.5B | $1M | $6.5B |
| Total DebtShort + long-term debt | $318M | $43.5B | $46.7B | $168M | $23.4B |
| Interest CoverageEBIT ÷ Interest expense | -0.27x | 69.44x | 17.22x | -0.04x | 9.42x |
Total Returns (Dividends Reinvested)
Evenly matched — AMTX and GEVO each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,464 today (with dividends reinvested), compared to $2,387 for AMTX. Over the past 12 months, AMTX leads with a +140.0% total return vs COP's +34.7%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs COP's 7.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +96.2% | +20.3% | +18.2% | -1.5% | +19.7% |
| 1-Year ReturnPast 12 months | +140.0% | +43.9% | +39.5% | +88.0% | +34.7% |
| 3-Year ReturnCumulative with dividends | +37.4% | +44.9% | +26.7% | +65.0% | +23.7% |
| 5-Year ReturnCumulative with dividends | -76.1% | +164.6% | +94.0% | -65.2% | +131.9% |
| 10-Year ReturnCumulative with dividends | +31.1% | +105.0% | +135.8% | -98.6% | +233.4% |
| CAGR (3Y)Annualised 3-year return | +11.2% | +13.2% | +8.2% | +18.2% | +7.3% |
Risk & Volatility
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVX currently trades 85.0% from its 52-week high vs GEVO's 68.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.46x | -0.15x | -0.05x | 1.64x | 0.08x |
| 52-Week HighHighest price in past year | $3.80 | $176.41 | $214.71 | $2.97 | $135.87 |
| 52-Week LowLowest price in past year | $1.22 | $101.19 | $133.77 | $1.01 | $84.28 |
| % of 52W HighCurrent price vs 52-week peak | +82.1% | +83.0% | +85.0% | +68.4% | +84.6% |
| RSI (14)Momentum oscillator 0–100 | 58.2 | 42.4 | 42.1 | 53.5 | 43.4 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 18.9M | 11.0M | 4.5M | 9.6M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AMTX as "Buy", XOM as "Hold", CVX as "Buy", GEVO as "Buy", COP as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -43.9% for AMTX (target: $2). For income investors, CVX offers the higher dividend yield at 3.76% vs XOM's 2.73%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $1.75 | $160.43 | $190.93 | $3.50 | $127.07 |
| # AnalystsCovering analysts | 7 | 55 | 53 | 14 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.7% | +3.8% | — | +2.8% |
| Dividend StreakConsecutive years of raises | — | 26 | 8 | — | 1 |
| Dividend / ShareAnnual DPS | — | $4.00 | $6.87 | — | $3.19 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.3% | +3.3% | 0.0% | +3.6% |
COP leads in 3 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 3 categories are tied.
AMTX vs XOM vs CVX vs GEVO vs COP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMTX or XOM or CVX or GEVO or COP a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 3% for Aemetis, Inc. (AMTX). ConocoPhillips (COP) offers the better valuation at 18. 1x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Aemetis, Inc. (AMTX) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMTX or XOM or CVX or GEVO or COP?
On trailing P/E, ConocoPhillips (COP) is the cheapest at 18.
1x versus Chevron Corporation at 27. 5x. On forward P/E, ConocoPhillips is actually cheaper at 13. 3x.
03Which is the better long-term investment — AMTX or XOM or CVX or GEVO or COP?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +164.
6%, compared to -76. 1% for Aemetis, Inc. (AMTX). Over 10 years, the gap is even starker: COP returned +233. 4% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMTX or XOM or CVX or GEVO or COP?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately -1226% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 36% for ConocoPhillips — giving it more financial flexibility in a downturn.
05Which is growing faster — AMTX or XOM or CVX or GEVO or COP?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -22. 3% for Aemetis, Inc. (AMTX). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -31. 8% for Chevron Corporation. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMTX or XOM or CVX or GEVO or COP?
ConocoPhillips (COP) is the more profitable company, earning 13.
6% net margin versus -37. 0% for Aemetis, Inc. — meaning it keeps 13. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COP leads at 19. 6% versus -17. 9% for AMTX. At the gross margin level — before operating expenses — CVX leads at 30. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMTX or XOM or CVX or GEVO or COP more undervalued right now?
On forward earnings alone, ConocoPhillips (COP) trades at 13.
3x forward P/E versus 15. 0x for Chevron Corporation — 1. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEVO: 72. 4% to $3. 50.
08Which pays a better dividend — AMTX or XOM or CVX or GEVO or COP?
In this comparison, CVX (3.
8% yield), COP (2. 8% yield), XOM (2. 7% yield) pay a dividend. AMTX, GEVO do not pay a meaningful dividend and should not be held primarily for income.
09Is AMTX or XOM or CVX or GEVO or COP better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +105. 0%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMTX and XOM and CVX and GEVO and COP?
These companies operate in different sectors (AMTX (Energy) and XOM (Energy) and CVX (Energy) and GEVO (Basic Materials) and COP (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AMTX is a small-cap quality compounder stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; GEVO is a small-cap high-growth stock; COP is a mid-cap quality compounder stock. XOM, CVX, COP pay a dividend while AMTX, GEVO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.